According to a recently published report on Cell Lines Market by Fact.MR, the global cell lines market is projected to record revenue growth of US$ 140 Mn through 2022. North America is anticipated to reign supreme in the global cell lines market with an estimated CAGR of over 3% through 2022, backed by the technological advancements in this region. Furthermore, the region’s high spending capacity on the research and development cost is expected to fuel the growth of the cell lines market.b The global cell lines market, the market is anticipated to show a moderate growth rate during the forecasted period of 2017-2022 and expected to reflect a value of more than US$ 140 Mn.
Demand for cell lines has been surging at a burgeoning rate, owing to its myriads of applications in the segments such as biochemistry, drug discovery, and molecular biology, among others. There has been a demand for effective treatment for the pervasive chronic diseases, which is met by the vaccines developed using cell lines.
Rapid adoption of regenerative medicines, enhanced healthcare expenditures, and rise in the funding in the biotechnology industry are some of the strong growth drivers of the cell lines market. Widespread detection of cancer has hard pressed the health organizations to develop an effective cure for the disease, which has been addressed by cell lines, attributed to its cost-effectiveness, pure cell population, and ease in use.
Request Free Sample Report Here:
The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global cell lines market. Product type, end user, application and region are key segments that define the growth of the global market for cell lines. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.
By product, the cancer cell lines segment reflects a higher market revenue share and reflects dominance over other segments in this category. On the other hand, ion channel cell lines are expected to grow at the higher pace comparatively to reflect growth at the CAGR of 3.8% during the period of forecast, 2017 to 2022. The cancer cell lines segment is expected to experience a higher gain in the BPs by the end of 2022 followed by the GPCR cell lines segment which is anticipated to be the second fast growing segment after ion channel cell line segment.
Browse Full Report with TOC:
North America the Most Lucrative Region
The North America region is the most attractive region for the cell lines market and this trend is expected to grow during the period of forecast. North America also possess high market attractiveness index and is expected to grow at a CAGR of 3.3% during the period of forecast of 2017 to 2022. The main reason for this region being a lucrative region for cell lines market is the investment done in the research and development. Moreover, the region is also characterized by a high technological background, and this elevates new paradigms for cell line development in the region and hence the market.
Cell Lines Market: Purview of the Report
The primary aim of the market study is to lend a holistic outlook to the stakeholders of the cell lines market with the help of a descriptive executive summary. The market has been analyzed for the period – 2017 – 2022, wherein 2017 is the base year and the forecast has been provided for 2018 to 2022. The market study commences with a brief explanation of the crucial market definitions, along with market valuation and analysis of the year-on-year growth.
A comprehensive study on the supply chain, pricing analysis, regulatory approval, cost structure, and sourcing of raw materials has been incorporated in the report. Brief information has been incorporated on the attractiveness of the market obtained by evaluating the market on the basis of product type, application, end user, and region.
The report comprises of a detailed analysis of the market at a regional level. The regions included in the report comprise of North America, Latin America, Europe, Japan, Asia Pacific except Japan (APEJ), Japan, and the Middle East and Asia (MEA). Brief analysis on each of these regions has been included in the report.
Behemoths profiled in the report constitutes of General Electric Company, Abzena Plc., Sigma-Aldrich Corporation, Selexis SA, WuXi AppTec Co., Ltd., Sartorius AG, Corning Incorporated, Lonza Group Ltd., Thermo Fisher Scientific, Inc., and American Type Culture Collection Inc. The report profiles comprehensive information on each of these players, along with their financials, market share, market size, and business strategies.